Purchase Order 75N92E18P00210

<p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $50,065.00 on September 7, 2017, for an Oxford Nanopore Starter Pack—a device providing ultra-long read DNA and RNA sequencing using nanopores. Work is performed in Bethesda, Maryland. The order carries a firm fixed price and was scheduled for completion by October 20, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $24,200 on January 16, 2019, with ultimate completion on March 11, 2019. Performance occurs at North Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Oxford Nanopore supplies next-generation genomic sequencing instruments, consumables, and reagents to federal research agencies, competing full-and-open across civilian health and research customers.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. valued at $10,000 on August 6, 2018, with completion on August 8, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The order is a firm-fixed-price purchase for next-generation sequencing instruments, consumables, or reagents—Oxford Nanopore's core product lines for federal research customers.</p>

<p>The NIH Clinical Center awarded a purchase order to Oxford Nanopore Technologies Inc. for $50,005.00 on September 7, 2018, with completion targeted for September 28, 2018. Performance takes place in Bethesda, Maryland. The order procures next-generation genomic sequencing instruments, consumables, or reagents on a firm fixed-price basis. The originating pre-solicitation was posted July 27, 2018, with bids due August 10, 2018.</p>

The National Human Genome Research Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for $165,000 on April 18, 2019, with a completion date of July 31, 2019. No set-aside applied. Place of performance is Cambridge, Massachusetts. The order procures next-generation sequencing instruments, consumables, and reagents—specifically PromethION 24 platform equipment and compatible flow cell packs and library preparation reagents for genomic sequencing research. The solicitation was...

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...

<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences Of California, Inc. on July 7, 2017, for $4,525.00 under firm fixed-price terms. Work is to be performed in North Bethesda, Maryland, with an ultimate completion date of August 6, 2017. The purchase order covers sequencing consumables or reagents supporting the institute's genomic research operations.</p>

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $57,000 purchase order to Oxford Nanopore Technologies Inc. to procure Grid ION Mk1 sequencing devices. The one-year firm fixed price contract, running from July 2021 through July 2022, will provide the sequencing devices requested in Solicitation Number NIH-NHGRI-21-100-SOL titled &quot;To Procure Grid ION Mk1 Sequencing Device.&quot; As the parent agency of the...

<p>The National Human Genome Research Institute awarded a purchase order to Pacific Biosciences of California, Inc. for $11,190.00 on December 4, 2017, with completion scheduled for January 3, 2018. The order is firm fixed price with no small business set-aside. Work is performed in North Bethesda, Maryland. The purchase order procures sequencing consumables or reagent kits for genomic research operations.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. valued at $19,792.44 on August 15, 2018, for DNA and RNA sequencing instruments, reagents, consumables, and bioinformatics software. Performance is at North Bethesda, Maryland, with an ultimate completion date of September 14, 2018. The order carries firm fixed price terms and no set-aside designation.</p>